Next Article in Journal
Improved Understanding of the High Shear Wet Granulation Process under the Paradigm of Quality by Design Using Salvia miltiorrhiza Granules
Next Article in Special Issue
Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System
Previous Article in Journal
Hyperthermia-Triggered Doxorubicin Release from Polymer-Coated Magnetic Nanorods
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings

1
Global Health and Global Development Divisions, Bill and Melinda Gates Foundation, Seattle, WA 98109, USA
2
Jenny Walsh Consulting Ltd.; Nottingham NG1 1GF, UK
3
School of Pharmacy, University College London, London WC1N 1AX, UK
*
Author to whom correspondence should be addressed.
Pharmaceutics 2019, 11(10), 518; https://doi.org/10.3390/pharmaceutics11100518
Submission received: 22 July 2019 / Revised: 1 October 2019 / Accepted: 1 October 2019 / Published: 8 October 2019
(This article belongs to the Special Issue Paediatric Drug Delivery)

Abstract

Despite advances in regulations and initiatives to increase pediatric medicine development, there is still an unmet need for age-appropriate medicines for children. The availability of pediatric formulations is particularly lacking in resource poor areas, due to, for example, area-specific disease burden and financial constraints, as well as disconnected supply chains and fragmented healthcare systems. The paucity of authorized pediatric medicines often results in the manipulation and administration of products intended for adults, with an increased risk of mis-dosing and adverse reactions. This article provides an overview of the some of the key difficulties associated with the development of pediatric medicines in both high and low resource areas, and highlights shared and location specific challenges and opportunities. The utilization of dispersible oral dosage forms and suppositories for low and middle-income countries (LMICs) are described in addition to other platform technologies that may in the future offer opportunities for future pediatric medicine development for low resource settings.
Keywords: pediatric; drug development; formulation; global health; dispersible; suppository pediatric; drug development; formulation; global health; dispersible; suppository
Graphical Abstract

Share and Cite

MDPI and ACS Style

Gerrard, S.E.; Walsh, J.; Bowers, N.; Salunke, S.; Hershenson, S. Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings. Pharmaceutics 2019, 11, 518. https://doi.org/10.3390/pharmaceutics11100518

AMA Style

Gerrard SE, Walsh J, Bowers N, Salunke S, Hershenson S. Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings. Pharmaceutics. 2019; 11(10):518. https://doi.org/10.3390/pharmaceutics11100518

Chicago/Turabian Style

Gerrard, Stephen E., Jennifer Walsh, Niya Bowers, Smita Salunke, and Susan Hershenson. 2019. "Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings" Pharmaceutics 11, no. 10: 518. https://doi.org/10.3390/pharmaceutics11100518

APA Style

Gerrard, S. E., Walsh, J., Bowers, N., Salunke, S., & Hershenson, S. (2019). Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings. Pharmaceutics, 11(10), 518. https://doi.org/10.3390/pharmaceutics11100518

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop